Acute and chronic angiotensin hypertension: Neural and nonneural components, time course, and dose dependency

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Li, Qian ^a   Dale, William E ^a   Hasser, Eileen M ^a   Blaine, Edward H ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

blood pressure; ganglion blockade; losartan; rats

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CHLORISONDAMINE; GANGLION BLOCKING AGENT; LOSARTAN; TRIMETAPHAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; GANGLION BLOCK; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NERVE TRACT; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0029794647     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.1.r200     Document Type: Article

References (45)

1. Bickerton, R. K., and J. P. Buckley. Evidence for a central mechanism in angiotensin-induced hypertension. Proc. Soc. Exp. Biol. Med. 106: 834-836, 1961.
2. Bishop, V. S., and J. R. Haywood. Hormonal control of cardiovascular reflexes. In: Reflex Control of the Circulation, edited by I. H. Zucker and J. P. Gilmore, Boca Raton, FL: CRC, 1991, p. 253-271.
3. Brooks, V. L., and J. W. Osborn. Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis. Am. J. Physiol. 268 (Regulatory Integrating Comp. Physiol. 37): R1343-R1358, 1995.
4. Brown, A. J., J. Casals-Stenzel, S. Gofford, A. F. Lever, and J. J. Morton. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am. J. Physiol 241 (Heart Circ. Physiol. 10): H381-H388, 1981.
5. Chiu, A. T., D. E. McCall, W. A. Price, P. C. Wong, D. J. Carini, J. V. Duncia, R. R. Wexler, S. E. Yoo, A. L. Johnson, and B. M. W. M. Timmermans. In vitro pharmacology of DuP 753. Am. J. Hypertens. 4: 282S-287S, 1991.
6. Clarke, P. B. S., I. Chaudieu, H. El-Bizri, P. Boksa, M. Quik, B. A. Esplin, and R. Capek. Pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br. J. Pharmacol. 111: 397-405, 1994.
7. Cowley, A. W., Jr. Long-term control of arterial blood pressure. Physiol. Rev. 72: 231-300, 1992.
8. Cowley, A. W., Jr., S. J. Switzer, and M. M. Skelton. Vasopressin, fluid, and electrolyte response to chronic angiotensin II infusion. Am. J. Physiol. 240 (Regulatory Integrative Comp. Physiol. 9): R130-R138, 1981.
9. Cox, B. F., and V. S. Bishop. Neural and humoral mechanisms of angiotensin-dependent hypertension. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1284-H1291, 1991.
10. Davis, J. O., and R. H. Freeman. Mechanisms regulating renin release. Physiol. Rev. 56: 1-56, 1976.
11. Doursout, M.-F., J. E. Chelly, C. H. Hartley, J. Szilagyi, J.-L. Montastruc, and J. P. Buckley. Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs. J. Pharmacol. Exp. Ther. 246: 591-596, 1988.
12. Fink, G. D., C. A. Bruner, and M. L. Mangiapane. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension Dallas 9: 355-361, 1987.
13. Fink, G. D., J. R. Haywood, W. J. Bryan, W. Packwood, and M. J. Brody. Central site for pressor action of blood-borne angiotensin in rat. Am. J. Physiol. 239 (Regulatory Integrative Comp. Physiol. 8): R358-R361, 1980.
14. Fink, G. D., J. R. Haywood, J. M. Owens, and C. A. Bruner. Sodium and central nervous system in chronic angiotensin-induced hypertension in the rat (Abstract). Federation Proc. 41: 1585, 1982
15. Folkow, B. The hemodynamic consequences of adaptive structural changes of the resistance vessels in hypertension. Clin. Sci. 41: 1-12, 1971.
16. Gorbea-Oppliger, V., and G. D. Fink. Clonidine reverses the slowly developing hypertension produced by low doses of angiotensin II. Hypertension Dallas 23: 844-847, 1994.
17. Gunther, S., M. A. Gimbrone, Jr., and R. W. Alexander. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature Lond. 287: 230-232, 1980.
18. Guyton, A. C., C. E. Jones, and T. G. Coleman. Circulatory Physiology: Cardiac Output and its Regulation. Philadelphia. PA: Saunders, 1973.
19. Hall, J. E. Control of sodium excretion by angiotensin II. intrarenal mechanisms and blood pressure regulation. Am. J Physiol. 250 (Regulatory Integrative Comp. Physiol. 19). R960-R972, 1986.
20. Hall, J. E., J. P. Granger, R. L. Hester, T. G. Coleman, M. R. Smith, Jr., and R. B. Cross. Mechanisms of escape from sodium retention during angiotensin II hypertension. Am. J. Physiol. 246 (Renal Fluid Electrolyte Physiol. 15): F627-F634, 1984.
21. Joy, M. D., and R, D. Lowe. Evidence that the area postrema mediates the central cardiovascular response to angiotensin II. Nature Lond. 228: 1303-1304, 1970.
22. Kanagy, N. L., C. M. Pawloski, and G. D. Fink. Role of aldosterone in angiotensin II-induced hypertension in rats. Am. J Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R102-R109, 1990.
23. King, S. J., J. W. Harding, and K. E. Moe. Elevated salt appetite and brain binding of angiotensin II in mineralocorticoid-treated rats. Brain Res. 448: 140-149, 1988.
24. Krieger, J. E., R. J. Roman, and A. W. Cowley, Jr. Hemodynamic and blood volume in angiotensin II salt-dependent hypertension in dogs. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1402-H1412, 1989.
25. Kurowski, S. Z., K. J. Slavik, and J. E. Szilagyi. A method for maintaining and protecting chronic arterial and venous catheters in conscious rats. J. Pharmacol. Methods 26: 249-256, 1991.
26. Lee, R. W., L. D. Lancaster, D. Buckley, and S. Goldman. Peripheral circulatory control of preload-afterload mismatch with angiotensin in dogs. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H126-H132, 1987.
27. Lever, A. F., F. Lyall, J. J. Morton, and B. Folkow. Angiotensin II, vascular structure and blood pressure. Kidney Int. 41, Suppl. 37: S-51-S-55, 1992.
28. Malik, K. U., and A. Nasjletti. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ. Res. 38: 26-30, 1976.
29. McCubbin, J. W., R. S. DeMoura, I. H. Page, and F. Olmsted. Arterial hypertension elicited by subpressor amounts of angiotensin. Science Wash. DC 149: 1394-1395, 1965.
30. Olmstead, F., and I. H. Page. Hemodynamic aspects of prolonged infusion of angiotensin into unanesthetized dogs. Circ. Res. 16: 140-149, 1965.
31. Osborn, J. W., and B. J. Hornfeld. Comparison of two ganglionic blockers to assess sympathetic tone in conscious rats (Abstract). FASEB J. 9: A337, 1995.
32. Osborn, J. W., Jr., M. E. Skelton, and A. W. Cowley, Jr. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats. Am. J. Physiol. 252 (Heart Circ. Physiol. 21): H628-H637, 1987.
33. Reid, I. A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E763-E778, 1992.
34. Reit, E. Actions of angiotensin on the adrenal medulla and autonomic ganglia. Federation Proc. 36: 1338-1343, 1972.
35. Severs, W. B., A. E. Daniels, H. H. Smookler, W. J. Kinnard, and J. P. Buckley. Interrelationship between angiotensin II and the sympathetic nervous system. J. Pharmacol. Exp. Ther. 153: 530-537, 1966.
36. Smits, G. J., P. J. Koepke, and E. H. Blaine. Reversal of low dose angiotensin hypertension by angiotensin receptor antagonists. Hypertension Dallas 18: 17-21, 1991.
37. Sweet, C. S., and E. H. Blaine. Angiotensin-converting enzyme inhibitors. In: Handbook of Hypertension: Pharmacology of Antihypertensive Drugs, edited by P. A. van Zwieten. New York: Elsevier, 1984. vol. 3, p. 343-363.
38. Tang, H., H. Shirai, and T. Inagami. Inhibition of protein kinase C prevents rapid desensitization of type 1B angiotensin II receptor. Circ. Res. 77. 239-248, 1995.
39. Thomas, W. G., and C. Sernier. Regulation of rat brain angiotensin II receptors by intravenous angiotensin II and low dietary sodium. Brain Res. 345: 54-61, 1985.
40. Ueda, H., Y. Uchida, K. Ueda, T. Gondaira, and S. Katayama. Centrally mediated vasopressor effect of angiotensin II in man. Jpn. Heart J. 10: 243-247, 1969.
41. Vari, R. C., S. Zinn, K. M. Verburg, and R. Freeman. Renal nerves and the pathogenesis of angiotensin-induced hypertension. Hypertension Dallas 9: 345-349, 1987.
42. Wong, P. C., W. A. Price, A. T. Chiu, J. V. Duncia, D. J. Carini, R. R. Wexler, A. L. Johnson, and B. M. W. M. Timmermans. In vivo pharmacology of DuP 753. Am. J. Hypertens. 4: 288S-298S, 1991.
43. Young, D. B., R. H. Murry, R. G. Bengis, and A. K. Markov. Experimental angiotensin II hypertension. Am. J. Physiol. 239 (Heart Circ. Physiol. 8): H391-H398, 1980.
44. Yu, R. and C. J. Dickenson. The progressive pressor response to angiotensin in the rabbit - the role of the sympathetic nervous system. Arch. Int. Pharmacodyn. Ther. 191: 24-36, 1971.
45. Zimmerman, B. G., S. K. Gomer, and J. C. Liao. Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release. Federation Proc. 31: 1344-1350, 1972.